Literatur
Al-Batran SE, Homann N, Schmalenberg H et al (2017) Perioperative chemotherapy with docetaxel, oxaliplatin, and fluorouracil/leucovorin (FLOT) versus epirubicin, cisplatin, and fluorouracil or capecitabine (ECF/ECX) for resectable gastric or gastroesophageal junction (GEJ) adenocarcinoma (FLOT4-AIO): A multicenter, randomized phase 3 trial. J Clin Oncol 35(suppl 15):4004A
Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M, Scarffe JH, Lofts FJ, Falk SJ, Iveson TJ, Smith DB, Langley RE, Verma M, Weeden S, Chua YJ (2006) MAGIC Trial Participants. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355(1):11–20
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
H. Alakus, A. Pamuk, F. Kütting und C. Bruns geben an, dass kein Interessenkonflikt besteht.
Rights and permissions
About this article
Cite this article
Alakus, H., Pamuk, A., Kütting, F. et al. Perioperative Chemotherapie beim lokal fortgeschrittenen Adenokarzinom des Magens oder ösophagogastralen Übergangs. Onkologe 25, 932–934 (2019). https://doi.org/10.1007/s00761-019-0637-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00761-019-0637-7